All these indicate that CD28 along with CD95 plays an essential role in lung cancer progression; however, decrease in CD28 expression was possibly the result of activation loss among Tef (especially CD3+ and CD8+), not Tregs, which especially in elderly people can lead to impaired immune response and tumor spread. This evidence concerns the gene CD8A and lung carcinoma.